Advertisement

Acute cardiomyopathy precipitated by lithium: is there a direct toxic effect on cardiac myocytes?

      Lithium is the drug of choice for bipolar disorder and has been in use for more than 50 years. Lithium is known to cause cardiac toxicity in humans including conduction disturbances, bradycardia, and repolarization abnormalities but has rarely been reported to cause left ventricular dysfunction. We report a patient with typical features of lithium toxicity including sinus bradycardia and junctional rhythm, who, in addition, presented atypical features with diffuse T-wave inversions, QT prolongation, and acute left ventricular systolic dysfunction with serum cardiac marker elevation. After excluding other causes of cardiomyopathy including coronary thrombosis, stress cardiomyopathy, and sepsis, a highly probable explanation for our patient’s acute left ventricular systolic dysfunction was lithium toxicity causing transient myocarditis. Extensive review of literature showed a few case reports of cardiac dysfunction associated with lithium, but acute left ventricular dysfunction caused by lithium has not been reported.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D; use, select 'Corporate R&D; Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Belmaker R.H.
        Bipolar disorder.
        N Engl J Med. 2004; 351: 476-486
        • Oruch R.
        • Elderbi M.A.
        • Khattab H.A.
        • Pryme I.F.
        • Lund A.
        Lithium: a review of pharmacology, clinical uses, and toxicity.
        Eur J Pharmacol. 2014; 740: 464-473
        • Brady H.R.
        • Horgan J.H.
        Lithium and the heart. Unanswered questions.
        Chest. 1988; 93: 166-169
        • Montastruc G.
        • Favreliere S.
        • Sommet A.
        • Pathak A.
        • Lapeyre-Mestre M.
        • Perault-Pochat M.C.
        • et al.
        Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance database.
        Br J Clin Pharmacol. 2010; 69: 287-294
        • Deligiannidis K.M.
        • Byatt N.
        • Freeman M.P.
        Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.
        J Clin Psychopharmacol. 2014; 34: 244-255
        • Wijeratne C.
        • Draper B.
        Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity.
        Aust N Z J Psychiatry. 2011; 45: 1026-1032
      1. Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association.
        Am J Psychiatry. 1994; 151: 1-36
        • Jope R.S.
        Anti-bipolar therapy: mechanism of action of lithium.
        Mol Psychiatry. 1999; 4: 117-128
        • Massot O.
        • Rousselle J.C.
        • Fillion M.P.
        • Januel D.
        • Plantefol M.
        • Fillion G.
        5-HT1B receptors: a novel target for lithium. possible involvement in mood disorders.
        Neuropsychopharmacology. 1999; 21: 530-541
        • Talati S.N.
        • Aslam A.F.
        • Vasavada B.
        Sinus node dysfunction in association with chronic lithium therapy: a case report and review of literature.
        Am J Ther. 2009; 16: 274-278
        • Singer I.
        • Rotenberg D.
        Mechanisms of lithium action.
        N Engl J Med. 1973; 289: 254-260
        • Offerman S.R.
        • Alsop J.A.
        • Lee J.
        • Holmes J.F.
        Hospitalized lithium overdose cases reported to the California Poison Control System.
        Clin Toxicol (Phila). 2010; 48: 443-448
        • Serinken M.
        • Karcioglu O.
        • Korkmaz A.
        Rarely seen cardiotoxicity of lithium overdose: complete heart block.
        Int J Cardiol. 2009; 132: 276-278
        • Phelan K.M.
        • Mosholder A.D.
        • Lu S.
        Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.
        J Clin Psychiatry. 2003; 64: 1328-1334
        • Demers R.G.
        • Heninger G.R.
        Electrocardiographic T-wave changes during lithium carbonate treatment.
        JAMA. 1971; 218: 381-386
        • Bucht G.
        • Smigan L.
        • Wahlin A.
        • Eriksson P.
        ECG changes during lithium therapy. A prospective study.
        Acta Med Scand. 1984; 216: 101-104
        • Mitchell J.E.
        • Mackenzie T.B.
        Cardiac effects of lithium therapy in man: a review.
        J Clin Psychiatry. 1982; 43: 47-51
        • Tilkian A.G.
        • Schroeder J.S.
        • Kao J.J.
        • Hultgren H.N.
        The cardiovascular effects of lithium in man. A review of the literature.
        Am J Med. 1976; 61: 665-670
        • Aichhorn W.
        • Huber R.
        • Stuppaeck C.
        • Whitworth A.B.
        Cardiomyopathy after long-term treatment with lithium—more than a coincidence?.
        J Psychopharmacol. 2006; 20: 589-591
        • Kitami M.
        • Oizumi H.
        • Kish S.J.
        • Furukawa Y.
        Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report.
        J Clin Psychopharmacol. 2014; 34: 410-411
        • Coulter D.M.
        • Bate A.
        • Meyboom R.H.
        • Lindquist M.
        • Edwards I.R.
        Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.
        BMJ. 2001; 322: 1207-1209
        • Prasad A.
        • Lerman A.
        • Rihal C.S.
        Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction.
        Am Heart J. 2008; 155: 408-417
        • Anantha Narayanan M.
        • Kandasamy V.V.
        • Chandraprakasam S.
        • Mooss A.
        Reversible stress cardiomyopathy presenting as acute coronary syndrome with elevated troponin in the absence of regional wall motion abnormalities: a forme fruste of stress cardiomyopathy?.
        Case Rep Med. 2014; 2014: 796202
        • Weisel R.D.
        • Vito L.
        • Dennis R.C.
        • Valeri C.R.
        • Hechtman H.B.
        Myocardial depression during sepsis.
        Am J Surg. 1977; 133: 512-521